Skip to main content

Neurelis Pipeline Update - Advancements to Address Unmet Needs in Neuroscience – Replay

Neurelis hosted an investor call to highlight updates on two of its neuroscience product development candidates, NRL-1004 for acute agitation episodes and NRL-1049 for cerebral cavernous malformations (CCMs).  A replay can be found at the link here.